Drug diversion remains a critical risk area for hospitals and health systems, particularly in environments where controlled substances are frequently handled and wasted, such as operating rooms. Technologies that verify the identity and concentration of liquid narcotics can play an important role in strengthening diversion prevention programs. WasteLog® is designed to provide rapid verification of controlled substances before waste procedures, helping organizations add a measurable layer of accountability to medication-handling workflows.

Using absorption spectroscopy technology, WasteLog® analyzes liquid controlled substances and delivers immediate qualitative measurement graphics on screen. The non-destructive sampling method allows organizations to retain material for follow-up testing if needed, while also supporting analysis of low dose concentrations. Test results can be exported to data analytics platforms, enabling pharmacy leadership and compliance teams to monitor patterns and strengthen diversion-detection strategies.

Operational flexibility is another key factor for facilities implementing diversion monitoring tools. WasteLog® is mobile, allowing teams to move the system between departments or even across facilities as needed. On-site calibration capabilities support evolving drug monitoring needs, while the ability to capture and review test results helps pharmacy leaders build a stronger, data-informed approach to controlled substance oversight.